SphingoTec Alternatives & Competitors
12 companies similar to SphingoTec — Improving patient outcomes with innovative diagnostics for acute care: Actionabl...
Companies similar to SphingoTec
Adrenomed AG
An innovative biomarker-guided precision medicine solution for patients in acute care with...
Hennigsdorf, Germany
Astute Medical
Enhancing rapid diagnosis and risk assessment in acute medical conditions through innovati...
Vasomune Therapeutics, Inc.
Biopharmaceutical leaders developing the next generation of medicine to normalize host vas...
Toronto, Canada
Kantum Pharma
Developing groundbreaking therapies and innovative diagnostics to help clinicians prevent...
Track all SphingoTec competitors
Get real-time alerts when any of these companies raise funding, hire, or show growth signals.
CardioRenal
Digital therapeutics for chronic cardiovascular disease
Strasbourg, France
Artrya Ltd
We are changing the way Coronary Heart Disease is diagnosed and treated.
Australia
Edwards Lifesciences IHFM
Global leader in the medical device industry with a patient-focused culture of innovation...
Naperville, United States
Renalytix
Transforming kidney disease care with one simple blood test.
New York, United States
Adela, Inc.
Advancing the field of epigenomics to transform how cancer is detected and monitored.
Foster City, United State...
Sola Diagnostics GmbH
The WID®-easy Test - Now also available in Switzerland 🇨🇭 👉 Unnecessary hysteroscopy and...
Innsbruck, Austria
Istanbul, Turkey
About SphingoTec
Founded in 2002, SphingoTec GmbH is a pioneering player in the Biotechnology sector, based in Germany. The company focuses on developing innovative biomarkers to diagnose, predict, and monitor acute medical conditions such as heart failure, kidney injury, and circulatory shock, with the aim of enhancing patient managem...
biomarker development, out-licensing of diagnostic solutions, critical care diagnostics, IVD assay provision
research laboratories, pharmaceutical companies, critical care units, clinicians, transplant centers
Innovative Diagnostics, Acute Care, Biomarkers, Acute Heart Failure, Acute Kidney Injury, Circulatory Shock, Patient Management, Treatment Strategies, Health Risk Prediction, Obesity Biomarkers, Cardiovascular Disease Biomarkers, Breast Cancer Biomarkers, Sepsis Diagnostics, In Vitro Diagnostics, Blood-based Protein Biomarkers
B2B, White Label
Licensing, Product Sales, Service Fee
Frequently Asked Questions
Don't just read about them. Follow them.
BounceWatch watches SphingoTec and millions of other companies. When one raises money, hires quickly or changes its product, we tell you the same day.
Compiled from the BounceWatch company index. We last looked at SphingoTec on 14 May 2026. The 12 companies listed here were last checked between 11 Sep 2024 and 9 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
